View as web page here.



It's Sunday, March 15th, 2020. Please enjoy ARK's weekly newsletter curated by our thematic analysts and designed to keep you engaged with disruptive innovation.

The Coronavirus Is Forcing a Grand Work-at-Home Experiment

Follow James on Twitter @jwangARK


The coronavirus crisis is precipitating the largest work-from-home experiment in history. Tech companies, universities, and governments are sending employees, staff, and students home to prevent infections and to work or study.


Working and studying from home requires software that works anywhere and enables collaboration. Companies like Salesforce, Workday, and Google have been pushing cloud software for more than a decade. Almost overnight, it has gone from nice-to-have to mission-critical.


Video conferencing company Zoom has been one of the notable beneficiaries of this virus. In recent weeks, usage and free trials have ticked up, with significant interest from China, a market that historically has shunned western SaaS products. During the past month, as the stock market has dropped, Zoom has gained 19%.1


Team communication software, Slack, also has attracted a “massive outpouring of interest”, especially from countries impacted by the coronavirus. With an easy to access free tier, it has seen an uptick in new signups and team creations, boding well for conversions to paid customers in the future.


For most software companies, the near-term impact probably will be negative. Both Slack and Adobe lowered guidance for the second quarter, citing greater uncertainty, travel restrictions, and lower odds that deals close.


While the coronavirus should accelerate the adoption of cloud software in the long term, valuations in the near term have compressed and could continue to compress until this risk-off period abates.


[1] Information derived from third party data source.



Sports Have Been Canceled: So What Do We Watch Now?

Follow Nick on Twitter @grousARK


For years, live sports have held the Pay-TV market together, but now that concerns about the coronavirus have forced the cancellation of collegiate and professional sporting events, online gaming is likely to pick up a lot of the slack. Sports fans might find that live-game streaming services like Twitch or Mixer are interesting, if not perfect, substitutes.


We believe live streaming gameplay is one of the hottest trends in the video gaming space. As shown in the chart below, since 2013 Twitch viewership has grown at 36.5% annually, with more than 11 billion hours viewed last year alone.

Screen Shot 2020-03-15 at 8.58.32 PM


President Trump Proposes an Additional $50 Billion in Small Business Administration Loans

Follow George on Twitter @GeorgeOfARK


On Wednesday evening, President Trump addressed the nation with the government’s response to the coronavirus (COVID-19). He proposed a number of initiatives including $50 billion for Small Business Administration (SBA) loans. The SBA sets guidelines for loans which ultimately are originated by partners, such as banks and community development organizations. To reduce the risk of making loans, the SBA guarantees up to 85% of each loan, enabling its partners to consider loan applicants they otherwise would not.


In our view, the SBA and alternative lenders such as PayPal, Stripe, Shopify and Square should work together to disburse loans. In 2019, Square facilitated 330,000 loans totaling $2.3 billion compared to the SBA’s 58,000 loans totaling $28 billion. In other words, the SBA loaned more than $450,000 on average to each business compared to Square’s $7,000, suggesting that Square is servicing many more truly small businesses. Moreover, Square can facilitate loans in 1-2 days compared to 2-3 weeks it takes the SBA.


By working together, the SBA and alternative lenders could disburse loans more effectively and efficiently to small businesses impacted adversely by the fallout from COVID-19.



Drones Could Mitigate Human Contact in Response to COVID-19

Follow Tasha on Twitter @TashaARK


This week, Matternet announced that it had developed a drone station to facilitate the delivery of medical specimens on hospital campuses. Available to hospitals on a subscription basis, Matternet allows drones to land and deliver payloads of diagnostics, pathology specimens, and medicine, while swapping out their batteries for return trips.


Matternet is partnering with Swiss Post in Switzerland and UPS in the US. Last October, UPS and Matternet received FAA approval to conduct some flights beyond visual line of sight, a critical step in enabling cost effective drone deliveries. As a result, one of their trial partners, WakeMed, has seen much faster and more predictable specimen deliveries. ARK estimates that, regulation permitting, drones will be able to deliver packages within 10 miles for just 25 cents, orders of magnitude cheaper than courier services.


Now that the COVID-19 crisis has spurred demand for contactless delivery, the adoption of delivery drones could accelerate. Regulators could step up their approval for certain use cases to facilitate rapid delivery solutions, especially now that self- quarantines will reduce the risk associated with flying above pedestrians. South Korea and China have been using drones to spray disinfectant and deliver medical samples and supplies.

Bitcoin Just Suffered Its Largest One-Day Drawdown in 7 years

Follow Yassine on Twitter @yassineARK


On Thursday, bitcoin experienced the second largest one-day price drawdown in its 10-year history. In fewer than 15 minutes, it fell from $7,200 to less than $5,400, breaking its 200-week moving average (WMA) decisively for the first time in roughly 7 years as it sank to $3,800, down nearly 40% in just hours.

As shown in the graph above, the severity of the selloff eclipsed all others except the 49% drawdown in April 2013.


The largest contributor to the selloff appeared to be bitcoin liquidations to satisfy margin calls on derivative exchanges allowing up to 100 times leverage. Bitmex, the largest crypto derivatives exchange, saw more than $700 million in liquidations of its bitcoin perpetual swap, the most over a 24 hour period in 16 months.


As bitcoin’s price crashed, the price of ether (ETH), the second largest cryptocurrency by network value, also experienced its largest daily selloff, down 43%. The severity of the selloff led to an unforeseen liquidity crunch in MakerDAO’s Keepers market, resulting in the involuntary liquidation of $4.5 million worth of collateralized debt positions (CDPs).  


As of this writing, both the price of bitcoin and ether have recovered, bitcoin up 47% from its low and hovering just above the 200 WMA.  We believe that crypto hedge funds and traders have more to learn about both the downside price spirals and the volatility associated with massive leverage in this nascent market.

Cash App Appears to Be Making Strides in Texas and California

Follow Max on Twitter @mfriedrichARK


Our previous analysis of Google Trends data has indicated that Cash App is highly popular in the south where unbanked rates are high. Square CEO Jack Dorsey also has alluded to this phenomenon.


We believe that what many analysts fail to understand is that Google Trends data is relative in scale and does not capture Cash App’s progress on an absolute basis. As can be seen in the chart below, Mississippi scores highest on Google Trends’ relative scale even though its population is below 3 million. Large states like Texas and New York score much lower on this basis.

Screen Shot 2020-03-15 at 9.26.07 PM
The picture changes when controlling for state populations, as shown below. According to our analysis, a large portion of Cash App’s customer acquisition could be moving toward Texas, Florida, California and New York, states with much larger populations than Mississippi and Louisiana. We will explain these and other findings in more detail in a forthcoming blog post.

Screen Shot 2020-03-15 at 9.27.18 PM

Invitae’s Acquisitions Strengthen its Rare Disease and Pharmacogenomic Testing 

Follow Simon on Twitter @sbarnettARK


Invitae (NVTA) recently announced that it is acquiring three companies: Diploid, Genelex, and YouScript. In our view, these acquisitions, respectively, will strengthen Invitae’s ability to diagnose rare diseases, conduct pharmacogenetic testing, and to improve clinical decision making. ARK believes Invitae will unlock latent demand with lower pricing, more comprehensive testing, and an easier order entry system. Its investments, both internal and external, also should lower cost-of-goods-sold (COGS) and translate into sustainable operating cash flows as it scales.


Roughly 4% of children are born with a rare genetic disease. Traditionally, it has taken five to seven years to reach a diagnosis. Consequently, nearly a third of these children haven’t survived past the age of five years. In contrast, thanks to genetic sequencing and symptom data, Diploid’s AI platform, Moon, identifies rare disease-causing mutations in a matter of minutes. Through its vertical integration, proprietary variant interpretation system (Sherloc), and now Moon, Invitae should be able to widen access to comprehensive genetic testing in neonatal and pediatric health care settings.


Genelex and YouScript enable Invitae to conduct pharmacogenomic (PGx) testing and to support patients throughout therapy. PGx testing has not been adopted widely because of logistics and prohibitive costs. Genelex offers PGx testing and analytic services to be embedded within Invitae’s variant interpretation system. YouScript offers clinicians support tools for PGx testing from information that already is embedded electronic health records at Cerner (CERN), Allscripts (MDRX), Epic, and other health care vendors. Once they are integrated into its platform, Invitae should avoid the logistical and cost burdens that have plagued PGx testing systems historically.


We hope you find this useful and please stay safe.

ARK's statements are not an endorsement of any company or a recommendation to buy, sell or hold any security. For a list of all purchases and sales made by ARK for client accounts during the past year that could be considered by the SEC as recommendations, click here. It should not be assumed that recommendations made in the future will be profitable or will equal the performance of the securities in this list. For full disclosures, click here.



3 East 28th Street, Floor 7
New York, NY 10016 United States

You received this email because you are subscribed to Research Newsletters from ARK Investment Management LLC.
Unsubscribe from ARK emails or choose the types of emails you want to receive. Unsubscribe from all.

This Newsletter is for informational purposes only and does not constitute, either explicitly or implicitly, any provision of services or products by ARK Investment Management LLC (“ARK”). Investors should determine for themselves whether a particular service or product is suitable for their investment needs or should seek such professional advice for their particular situation. All content is original and has been researched and produced by ARK unless otherwise stated therein. No part of the content may be reproduced in any form, or referred to in any other publication, without the express written permission of ARK. All statements made regarding companies, securities or other financial information contained in the content or articles relating to ARK are strictly beliefs and points of view held by ARK and are not endorsements of any company or security or recommendations to buy or sell any security. By visiting and/or otherwise using the ARK website in any way, you indicate that you understand and accept the terms of use as set forth on the website and agree to be bound by them. If you do not agree to the terms of use of the website, please do no access the website or any pages thereof. Any descriptions of, references to, or links to other products, publications or services does not constitute an endorsement, authorization, sponsorship by or affiliation with ARK with respect to any linked site or its sponsor, unless expressly stated by ARK. Any such information, products or sites have not necessarily been reviewed by ARK and are provided or maintained by third parties over whom ARK exercises no control. ARK expressly disclaims any responsibility for the content, the accuracy of the information, and/or quality of products or services provided by or advertised on these third-party sites.